Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Revenue (2020 - 2025)

BioAtla (BCAB) has disclosed Revenue for 4 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • For Q4 2025, Revenue changed N/A year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, down 81.82%, while the annual FY2025 figure was $2.0 million, 81.82% down from the prior year.
  • Revenue hit $2.0 million in Q4 2025 for BioAtla, down from $11.0 million in the prior quarter.
  • Across five years, Revenue topped out at $11.0 million in Q3 2024 and bottomed at $250000.0 in Q2 2021.
  • Average Revenue over 3 years is $4.4 million, with a median of $2.0 million recorded in 2025.
  • On a YoY basis, Revenue climbed as much as 31.58% in 2021 and fell as far as 31.58% in 2021.
  • BioAtla's Revenue stood at $250000.0 in 2021, then surged by 4300.0% to $11.0 million in 2024, then plummeted by 81.82% to $2.0 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $2.0 million, $11.0 million, and $250000.0 for Q4 2025, Q3 2024, and Q2 2021 respectively.